TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ENTERAL FEEDING FORMULA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING NUMBER OF PRETERM BIRTH
3.1.2 GROWING NUMBER OF CHRONIC DISEASES
3.1.3 GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY
3.1.4 GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION
3.2 RESTRAINTS
3.2.1 RISK ASSOCIATED WITH THE ENTERAL TUBE FEEDING
3.2.2 STRICT REGULATION OF USAGE FOR PATIENTS SAFETY
3.3 OPPORTUNITIES
3.3.1 GROWTH IN HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES
3.4 CHALLENGES
3.4.1 INSUFFICIENT REIMBURSEMENTS POLICIES
3.4.2 LACK OF TRAINED STAFF
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 STANDARD FORMULAS
6.2.1 MONOMERIC
6.2.2 POLYMERIC
6.3 DISEASE SPECIFIC
6.3.1 DIABETIC FORMULAS
6.3.2 RENAL FORMULAS
6.3.3 HEPATIC FORMULAS
6.3.4 PULMONARY FORMULAS
6.3.5 OTHERS
7 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CRITICAL CARE
7.3 GASTROENTEROLOGY
7.4 ONCOLOGY
7.5 NEUROLOGY
7.6 DIABETES
7.7 OTHERS
8 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING
8.1 OVERVIEW
8.2 GASTRIC TUBE FEEDING
8.3 NASOGASTRIC TUBE FEEDING
8.4 GASTROTOMY TUBE FEEDING
8.5 DUODENAL OR JEJUNAL TUBE FEEDING
9 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY STAGE
9.1 OVERVIEW
9.2 ADULT
9.3 PEDIATRIC
10 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 LONG TERM CARE FACILITIES
10.3.1 HOME CARE AGENCIES AND HOSPICES
10.3.2 NURSING HOMES
10.3.3 ASSISTED LIVING FACILITIES
11 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS; NORTH AMERICA
13 COMPANY PROFILE
13.1 ABBOTT
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 NESTL?
13.2.1 COMPANY OVERVIEW
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 MEIJI HOLDINGS CO., LTD.
13.3.1 COMPANY OVERVIEW
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 B. BRAUN MELSUNGEN AG
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 DANONE NUTRICIA
13.5.1 COMPANY SNAPSHOT
13.5.2 GEOGRAPHICAL PRESENCE
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 FRESENIUS SE & CO. KGAA
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 NORTH AMERICA HEALTH PRODUCTS, INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 HORMEL FOODS, LLC
13.8.1 COMPANY SNAPSHOT
13.8.2 GEOGRAPHICAL PRESENCE
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 MEAD JOHNSON & COMPANY, LLC.
13.9.1 COMPANY SNAPSHOT
13.9.2 GEOGRAPHICAL PRESENCE
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.10 MEDLINE INDUSTRIES, INC
13.10.1 COMPANY SNAPSHOT
13.10.2 GEOGRAPHICAL PRESENCE
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENTS
13.11 MEDTRITION, INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 NO RECENT DEVELOPMENTS
13.12 NUTRITIONAL MEDICINALS, LLC
13.12.1 COMPANY SNAPSHOT
13.12.2 GEOGRAPHICAL PRESENCE
13.12.3 PRODUCT PORTFOLIO
13.12.4 NO RECENT DEVELOPMENTS
13.13 REAL FOOD BLENDS
13.13.1 COMPANY SNAPSHOT
13.13.2 PRODUCT PORTFOLIO
13.13.3 RECENT DEVELOPMENTS
13.14 VICTUS
13.14.1 COMPANY SNAPSHOT
13.14.2 PRODUCT PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
14 RELATED REPORTS